Genscript Biotech Co. (OTCMKTS:GNNSF) Short Interest Update

Genscript Biotech Co. (OTCMKTS:GNNSF) was the recipient of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 549,600 shares, a decline of 70.6% from the January 31st total of 1,867,800 shares. Based on an average trading volume of 200 shares, the short-interest ratio is presently 2,748.0 days.

Genscript Biotech Stock Performance

Genscript Biotech stock remained flat at C$1.90 during mid-day trading on Friday. The stock has a 50 day moving average of C$1.39 and a 200-day moving average of C$1.41. Genscript Biotech has a fifty-two week low of C$1.05 and a fifty-two week high of C$2.05.

Genscript Biotech Company Profile

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.